Flavin-containing monooxygenase system
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
The Flavin-containing monooxygenase (FMO) system is used for oxidation reactions in drug metabolism. The major difference between this system and the Cytochrome P450 monooxygenase system is that the FMO system does not act to oxidize carbon atoms. Also in contrast to P450, the FMO system is not induced by exposure to drugs or environmental pollutants.
The FMO system is distinct from the cytrochrome P450 system in that it is non-inducible, does not have a heme prosthetic group but both require NADPH and oxygen; multiple isozymes are known for both; and they are both localized in microsomes of the endoplasmic reticulum.